ACIP Updates Recommendation on COVID-19 Vaccine Intervals By Diana Ernst, RPh Publish Date January 22, 2021
Cabenuva Approved as First Long-Acting Injectable for HIV Treatment By Brian Park, PharmD Publish Date January 22, 2021
Bamlanivimab Promising for COVID-19 Prevention in Long-Term Care Facilities By Brian Park, PharmD Publish Date January 21, 2021
FDA to Review Additional GI Cancer Indications for Nivolumab By Brian Park, PharmD Publish Date January 21, 2021
Pirfenidone Gets Priority Review for Unclassifiable Interstitial Lung Disease By Diana Ernst, RPh Publish Date January 21, 2021
Chlorthalidone Compared With HCTZ for MACE Reduction By Diana Ernst, RPh Publish Date January 21, 2021
Combined Modalities Improve Survival in Stage III Inoperable NSCLC By Andrea S. Blevins Primeau, PhD, MBA Publish Date January 21, 2021
Verquvo Approved for Heart Failure with Reduced Ejection Fraction By Brian Park, PharmD Publish Date January 20, 2021
FDA: Update on Blood Donation During COVID-19 Pandemic By Brian Park, PharmD Publish Date January 20, 2021
Narsoplimab Under Review for Stem Cell Transplant-Associated Thrombotic Microangiopathy By Brian Park, PharmD Publish Date January 19, 2021
Potential Med Errors Prompt FDA Action on Vinca Alkaloid Labeling By Diana Ernst, RPh Publish Date January 19, 2021
First Treatment for Newly Diagnosed Light Chain Amyloidosis Approved By Brian Park, PharmD Publish Date January 19, 2021
Xalkori Approved for Anaplastic Large Cell Lymphoma in Children, Young Adults By Brian Park, PharmD Publish Date January 15, 2021
